BHALLA NARINDER PAL (Chief Medical Officer) received a stock award from LEXEO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/28/2026ACC: 0002109299-26-000009
Officer· Chief Medical Officer
Since Feb 2026
+57.46K
Net shares
Net buyer
$9.7K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
57.46K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.71K
Price / share
$3.58
Trade value
$9.71K
% of position
3.3%
9/14/2026
82.19K→84.91K
Total
Net shares
+2.71K
Net value
$9.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | A · Award | +2.71K | $3.58 | $9.71K | 3.3% | 82.19K | 84.91K |
| Total | +2.71K | $9.71K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
54.75K shares
Shares
+54.75K
Strike price
3.39
Held after
54.75K
Exercisable
—
9/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock54.75K shares | 9/24/2026 | A · Award | +54.75K | 3.39 | — | 54.75K |